Regulatory T cells in HBV and HCV liver diseases: implication of regulatory T lymphocytes in the control of immune response

Bibliography

• Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics. Cancer J Clin 2002;55:74-108
   Web of Science ®Google Scholar
• Dick EA, Taylor-Robinson SD, Thomas HC, Gedroyc WM. Ablative therapy for liver tumours. Gut 2002;50:733-9
   PubMed Web of Science ®Google Scholar
• Levy I, Sherman M; Liver Cancer Study Group of the University of Toronto. Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto. Gut 2002;50:881-5
   PubMed Web of Science ®Google Scholar
• Wada Y, Nakashima O, Kutami R, Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration. Hepatology 1998;27:407-14
   PubMed Web of Science ®Google Scholar
• Chouaib S, Asselin-Paturel C, Mami-Chouaib F, The host-tumor immune conflict: from immunosuppression to resistance and destruction. Immunol Today 1997;18:493-7
   PubMedGoogle Scholar
• Belkaid Y, Rouse BT. Natural regulatory T cells in infectious disease. Nat Immunol 2005;6:353-60
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Sakaguchi N, Asano M, Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor a-chains (CD25). J Immunol 1995;155:1151-64
   PubMed Web of Science ®Google Scholar
• Liu W, Putnam AL, Xu-Yu Z, CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 2006;7:1701
   Google Scholar
• Hori S, Nomura T, Sakagushi S. Control of regulatory T cells development by the transcription factor FoxP3. Science 2003;299:1057-61
   PubMed Web of Science ®Google Scholar
• Kleinewietfeld M, Starke M, Di Mitri D, CD49d provides access to “untouched” human FoxP3+ Treg free of contamining effector cells. Blood 2009;113(4):827
   PubMed Web of Science ®Google Scholar
• Burchill MA, Yang J, Vang KB, Farrar MA. Interleukin-2 receptor signaling in regulatory T cell development and homeostasis. Immunol Lett 2007;114(1):1-8
   PubMed Web of Science ®Google Scholar
• Takahata Y, Nomura A, Takada H, CD25+CD4+ T cells in human cord blood: an immunoregulatory subset with naive phenotype and specific expression of forkhead box p3 (Foxp3) gene. Exp Hematol 2004;32(7):622-9
   PubMed Web of Science ®Google Scholar
• Thornton AM, Shevach EM. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998;188(2):287-96
   PubMed Web of Science ®Google Scholar
• Thornton AM, Shevach EM. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J Immunol 2000;164(1):183-90
   PubMed Web of Science ®Google Scholar
• Piccirillo CA, Shevach EM. Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells. J Immunol 2001;167(3):1137-40
   PubMed Web of Science ®Google Scholar
• Bystry RS, Aluvihare V, Welch KA, B cells and professional APCs recruit regulatory T cells via CCL4. Nat Immunol 2001;2(12):1126-32
   PubMed Web of Science ®Google Scholar
• Onizuka S, Tawara I, Shimizu J, Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. Cancer Res 1999;59(13):3128-33
   PubMed Web of Science ®Google Scholar
• Shimizu J, Yamazaki S, Sakaguchi S. Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. Immunology 2002;107(1):5-9
   PubMedGoogle Scholar
• Gallimore A, Sakaguchi S. Regulation of tumour immunity by CD25+ T cells. Immunology 2002;107(1):5
   PubMed Web of Science ®Google Scholar
• Levings MK, Gregori S, Tresoldi E, Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Treg cells. Blood 2005;105:1162-9
   PubMed Web of Science ®Google Scholar
• Groux H, O'Garra A, Bigler M, A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevent colitis. Nature 1997;389:737-42
   PubMed Web of Science ®Google Scholar
• Groux H. Type 1 T-regulatory cells: their role in the control of immune responses. Transplantation 2003;75(9 Suppl):8S-12S
   PubMed Web of Science ®Google Scholar
• McGuirk P, McCann C, Mills KH. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J Exp Med 2002;195(2):221-31
   PubMed Web of Science ®Google Scholar
• Rahmoun M, Foussat A, Groux H, Enhanced frequency of CD18- and CD49b-expressing T cells in peripheral blood of asthmatic patients correlates with disease severity. Int Arch Allergy Immunol 2006;140:139-49
   PubMed Web of Science ®Google Scholar
• Aandahl EM, Michaelsson J, Moretto WJ, Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J Virol 2004;78:2454-9
   PubMed Web of Science ®Google Scholar
• Cabrera R, Tu Z, Xu Y, An immunomodulatory role for CD4 (+) CD25 (+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology 2004;40:1062-71
   PubMed Web of Science ®Google Scholar
• Kinter AL, Hennessey M, Bell A, CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J Exp Med 2004;200:331-43
   PubMed Web of Science ®Google Scholar
• Barnaba V, Zaccari C, Levrero M, Immunoregulatory T cells in HBV-induced chronic liver disease as defined by monoclonal antibodies. Clin Immunol Immunopathol 1983;26:83-90
   PubMedGoogle Scholar
• Lemm G, Salzer K, Warnatz H. Studies on immunoregulatory mechanisms in acute and chronic hepatitis B. Clin Exp Immunol 1983;52:250-8
   PubMed Web of Science ®Google Scholar
• Roh S, Kim K. Overcoming tolerance in hepatitis B virus transgenic mice: a possible involvement of regulatory T cells. Microbiol Immunol 2003;47:453-60
   PubMed Web of Science ®Google Scholar
• Chisari FV, Filippi P, Buras J, Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice. Proc Natl Acad Sci USA 1987;84:6909-13
   PubMed Web of Science ®Google Scholar
• Thio CL, Mosbruger TL, Kaslow RA, Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection. J Virol 2004;78:11258-62
   PubMed Web of Science ®Google Scholar
• Stoop JN, van der Molen RG, Baan CC, Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology 2005;41:771-8
   PubMed Web of Science ®Google Scholar
• Franzese O, Kennedy PT, Gehring AJ, Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection. J Virol 2005;79:3322-8
   PubMed Web of Science ®Google Scholar
• Xu D, Fu J, Jin L, Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol 2006;177:739-47
   PubMed Web of Science ®Google Scholar
• Hyodo N, Nakamura I, Imawari M. Hepatitis B core antigen stimulates interleukin-10 secretion by both T cells and monocytes from peripheral blood of patients with chronic hepatitis B virus infection. Clin Exp Immunol 2004;135:462-6
   Google Scholar
• Peng G, Li S, Wu W, Circulating CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B infection. Immunology 2008;123(1):57-65
   PubMed Web of Science ®Google Scholar
• Yang G, Liu A, Xie Q, Association of CD4+CD25+Foxp3+ regulatory T cells with chronic activity and viral clearance in patients with hepatitis B. Int Immunol 2007;19(2):133-40
   PubMed Web of Science ®Google Scholar
• Nan XP, Zhang Y, Yu HT, Circulating CD4+CD25high regulatory T cells and expression of PD-1 and BTLA on CD4+ T cells in patients with chronic hepatitis B virus infection. Viral Immunol 2010;23(1):63-70
   PubMed Web of Science ®Google Scholar
• Lin CY, Tsai MC, Huang CT, Liver injury is associated with enhanced regulatory T-cell activity in patients with chronic hepatitis B. J Viral Hepat 2007;14(7):503-11
   PubMed Web of Science ®Google Scholar
• Stoop JN, Claassen MA, Woltman AM, Intrahepatic regulatory T cells are phenotypically distinct from their peripheral counterparts in chronic HBV patients. Clin Immunol 2008;129(3):419-27
   PubMed Web of Science ®Google Scholar
• Fu J, Xu D, Liu Z, Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology 2007;132(7):2328-39
   PubMed Web of Science ®Google Scholar
• Ward J, Robinson PJ. How to detect hepatocellular carcinoma in cirrhosis. Eur Radiol 2002;9:2258-72
   Google Scholar
• Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol 2007;13:2436-41
   PubMed Web of Science ®Google Scholar
• Pham TNG, Michalak TI. Occult persistence and lymphotropism of hepatitis C virus infection. World J Gastroenterol 2008;14(18):2789-93
   PubMed Web of Science ®Google Scholar
• Muir AJ, Bornstein JD, Killenberg PG; Atlantic Coast Hepatitis Treatment Group. Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites. N Engl J Med 2004;350:2265-71
   PubMed Web of Science ®Google Scholar
• Schlenker C, Trotter J. Recurrent hepatitis C following liver transplantation: a review of factors associated with graft injury. Minerva Gastroenterol Dietol 2006;52:175-86
   PubMedGoogle Scholar
• Roche B, Samuel D. Risk factors for hepatitis C recurrence after liver transplantation. J Viral Hepat 2007;14(Suppl 1):89-96
   PubMedGoogle Scholar
• Ercolani G, Grazi GL, Ravaioli M, Histological recurrent hepatitis C after liver transplantation: outcome and role of retransplantation. Liver Transpl 2006;12:1104-11
   PubMed Web of Science ®Google Scholar
• Velidedeoglu E, Mange KC, Frank A, Factors differentially correlated with the outcome of liver transplantation on HCV+ and HCV- recipients. Transplantation 2004;77:1834-42
   PubMed Web of Science ®Google Scholar
• Feray C, Gigou M, Samuel D, Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after transplantation. Gastroenterology 1995;108:1088-96
   PubMed Web of Science ®Google Scholar
• Ciuffreda D, Codarri L, Buhler L, Hepatitis C virus infection after liver transplantation is associated with lower levels of activated CD4(+)CD25(+)CD45RO(+)IL-7ralpha(high) T cells. Liver Transpl 2010;16(1):49-55
   PubMed Web of Science ®Google Scholar
• Langhans B, Braunschweiger I, Arndt S, Core-specific adaptive regulatory T-cells in different outcomes of hepatitis C. Clin Sci 2010;119(2):97-109
   PubMed Web of Science ®Google Scholar
• Gerlach JT, Diepolder HM, Jung MC, Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. Gastroenterology 1999;117:933-41
   PubMed Web of Science ®Google Scholar
• Wedemeyer H, He XS, Nascimbeni M, Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol 2002;169:3447-58
   PubMed Web of Science ®Google Scholar
• Dittmer U, He H, Messer RJ, Functional impairment of CD8(+) T cells by regulatory T cells during persistent retroviral infection. Immunity 2004;20:293-303
   PubMed Web of Science ®Google Scholar
• Sugimoto K, Ikeda F, Stadanlick J, Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology 2003;38:1437-48
   PubMed Web of Science ®Google Scholar
• Bolacchi F, Sinistro A, Ciaprini C, Increased hepatitis C virus (HCV)-specific CD4+CD25+ regulatory T lymphocytes and reduced HCV-specific CD4+ T cell response in HCV-infected patients with normal versus abnormal alanine aminotransferase levels. Clin Exp Immunol 2006;144:188-96
   PubMed Web of Science ®Google Scholar
• Yang JH, Zhang YX, Yu RB, CD4+ CD25+ regulatory T cells suppress CD4+ T cell responses in patients with persistent hepatitis C virus infection. Zhonghua Nei Ke Za Zhi 2006;45:29-33
   PubMedGoogle Scholar
• Akiyama M, Ichikawa T, Miyaaki H, Relationship between regulatory T cells and the combination of pegylated interferon and ribavirin for the treatment of chronic hepatitis type C. Intervirology 2010;53(3):154-60
   PubMed Web of Science ®Google Scholar
• Itose I, Kanto T, Kakita N, Enhanced ability of regulatory T cells in chronic hepatitis C patients with persistently normal alanine aminotransferase levels than those with active hepatitis. J Viral Hepat 2009;16(12):844-52
   PubMed Web of Science ®Google Scholar
• Delhem N, Cottrez F, Carpentier A, Role of the regulatory T lymphocytes in hepatitis C fibrosis progression. Bull Cancer 2008;95(11):1029-38
   PubMed Web of Science ®Google Scholar
• Carpentier A, Conti F, Carriere M, Analysis of gene transcription in sera during chronic hepatitis C infection. J Med Virol 2009;81(3):473-80
   PubMed Web of Science ®Google Scholar
• Wang JP, Zhang Y, Wei X, Circulating Toll-like receptor (TLR) 2, TLR4, and regulatory T cells in patients with chronic hepatitis C. APMIS 2010;118(4):261-70
   PubMed Web of Science ®Google Scholar
• Claassen MA, de Knegt RJ, Tilanus HW, Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosis. J Hepat 2010;52(3):315-21
   PubMed Web of Science ®Google Scholar
• Yoshizawa K, Abe H, Kubo Y, Expansion of CD4(+)CD25(+)FoxP3(+) regulatory T cells in hepatitis C virus-related chronic hepatitis, cirrhosis and hepatocellular carcinoma. Hepatol Res 2010;40(2):179-87
   PubMed Web of Science ®Google Scholar
• Smyk-Pearson S, Golden-Mason L, Klarquist J, Functional suppression by FoxP3+CD4+CD25(high) regulatory T cells during acute hepatitis C virus infection. J Infect Dis 2008;197(1):46-57
   PubMed Web of Science ®Google Scholar
• Carpentier A, Conti F, Stenard F, Increased expression of regulatory Tr1 cells in recurrent hepatitis C after liver transplantation. Am J Transplant 2009;9(9):2102-12
   PubMed Web of Science ®Google Scholar
• Perrella A, Arenga G, Pisaniello D, Elevated CD4+/CD25+ T-cell frequency and function during hepatitis C virus recurrence after liver transplantation. Transplant Proc 2009;41(5):1761-6
   PubMed Web of Science ®Google Scholar
• Miroux C, Morales O, Carpentier A, Inhibitory effects of cyclosporine on human regulatory T cells in vitro. Transplant Proc 2009;41(8):3371-4
   PubMed Web of Science ®Google Scholar
• Rayhill SC, Barbeito R, Katz D, A cyclosporine-based immunosuppression regimen may be better than tacrolimus for long-term liver allograft survival in recipients transplanted for hepatitis C. Transplant Proc 2006;38:3625
   PubMed Web of Science ®Google Scholar
• Villamil F, Levy G, Grazi GL, Long-term outcomes in liver transplant patients with hepatic C infection receiving tacrolimus or cyclosporine. Transplant Proc 2006;38:2964
   PubMed Web of Science ®Google Scholar
• Accapezzato D, Francavilla V, Paroli M, Hepatic expansion of a virus-specific regulatory CD8+ T cell population in chronic HCV infection. J Clin Invest 2004;113:963-97
   PubMed Web of Science ®Google Scholar
• Andre P, Komurian-Pradel F, Deforges S, Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J Virol 2002;76(14):6919-28
   PubMed Web of Science ®Google Scholar
• Jiang ZH, Zhang ZY, He M, The screening and identification of Apolipoprotein A-II from serum differential proteins in hepatocellular carcinoma patients. Zhonghua Gan Zang Bing Za Zhi 2010;18(6):445-9
   PubMedGoogle Scholar
• Perlemuter G, Sabile A, Letteron P, Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis. FASEB J 2002;16(2):185-94
   PubMed Web of Science ®Google Scholar
• Lee J, Suh WI, Shin EC. T-cell dysfunction and inhibitory receptors in hepatitis C virus infection. Immune Netw 2010;10(4):120-5
   PubMedGoogle Scholar
• Wu W, Li J, Chen F, Circulating Th17 cells frequency is associated with the disease progression in HBV infected patients. Gastroenterol Hepatol 2010;25(4):750-7
   Google Scholar
• Wilhelm AJ, Zabalawi M, Owen JS, Apolipoprotein A-I modulates regulatory T cells in autoimmune LDLr-/-, ApoA-I-/- mice. J Biol Chem 2010. [Epub ahead of print]
   Google Scholar